MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia"

  • 2025 International Congress

    Modeling Dementia in Patients with Parkinson’s Disease Years After DBS

    S. Gunawardena, E. Assaedi, T. George, C. Sonneborn, D. Floden (Cleveland, USA)

    Objective: The objective of this study is to identify pre-operative cognitive characteristics of patients who are candidates for deep brain stimulation surgery that may contribute…
  • 2025 International Congress

    Development of the Lewy Body Dementia Domain Rating Scale (LBD-DRS): A disease-specific outcome measure

    E. Matar, B. Boeve, J. Kane, F. Rodriguez-Porcel, A. Schrag, S. Sikkes, J. Taylor (New South Wales, Australia)

    Objective: To develop and refine the Lewy Body Dementia Domain Rating Scale (LBD-DRS) as a disease-specific outcome measure tailored to the unique clinical features of…
  • 2025 International Congress

    Baseline cerebrospinal levels of p-tau and amyloid beta and striatal dopamine transporter binding predict mild cognitive impairment and dementia diagnosis in Parkinson’s disease

    L. Collins-Praino, A. Mcnamara, I. Baetu (Adelaide, Australia)

    Objective: To assess whether baseline measurements of neuroimaging and biofluid-based biomarkers predict diagnosis of mild cognitive impairment (MCI) and dementia at 5-year follow-up in early…
  • 2025 International Congress

    Exploring the Association of APOE Polymorphism and the Clinical Course of CSF1R-Related Disorder

    A. Strongosky, T. Chmiela, M. Baker, Z. Wszolek (Jacksonville, USA)

    Objective: To assess the frequency of APOE alleles and their association with clinical course of Colony Stimulating Factor 1 Receptor-Related Disorder (CSF1R-RD). Background: CSF1R-RD is…
  • 2025 International Congress

    Cognitive Decline in Parkinson’s Disease: A Decade-Long Registry Analysis of Prevalence and Risk Factors

    L. Ge, K. Asai, K. Ogawa, K. Ikenaka, Y. Kimura, H. Mochizuki (Suita, Japan)

    Objective: This study aims to identify predictors of cognitive decline in cognitively normal Parkinson’s disease patients by analyzing the 10 years-long PD registry. Background: Cognitive…
  • 2025 International Congress

    Clinical and Pathological Features of CSF1R-Related Disorder Associated with the c.2330G>A, p.R777Q Pathogenic Variant

    T. Chmiela, A. Strongosky, D. Dickson, Z. Wszolek (Katowice, Poland)

    Objective: To report the clinical and pathological features of CSF1R-RD associated with the c.2330G>A, p.R777Q variant, and to report a new family carrying this variant.…
  • 2025 International Congress

    Long-Term Dementia Risk in the General Parkinson Disease Population

    J. Maple-Grødem, ø. Rustan, D. Bäckström, M. Camacho, C. Counsell, I. Dalen, L. Forsgren, R. Lawson, A. Macleod, C. Williams-Gray, A. Yarnall, OB. Tysnes, G. Alves (Stavanger, Norway)

    Objective: To estimate the long-term risk of developing dementia in the general Parkinson’s disease (PD) population and to assess the influence of age at PD…
  • 2025 International Congress

    Gait Analysis and Outcome of CSF Drainage in Patients of Normal Pressure Hydrocephalus

    S. Patel, C. Sankhla (Mumbai, India)

    Objective: NPH is a clinical entity causing impairment in gait, bladder and memory functions. Of these, gait dysfunction is the most prominent and disabling as…
  • 2025 International Congress

    Co-Occurrence of DAT Scan, Amyloid PET Scan, and Alzheimer’s Genetic Screening Abnormalities in Patient with Early-Onset Neurocognitive Decline: A Case Report

    A. Mason, R. Payne, N. Shneyder, E. Baldinger (Tampa, USA)

    Objective: The presented case report aims to show the possible overlap between causes of neurocognitive decline and the importance of considering comorbidities when discussing anti-amyloid monoclonal…
  • 2025 International Congress

    Expanding the Geographic Spectrum of Guam Complex: A Case Report from Colombia

    A. Alonso, L. Granados, A. Ferreiros (Bogotá, Colombia)

    Objective: To describe the case of a patient presenting with a progressive neurodegenerative syndrome characterized by the coexistence of dementia, parkinsonism, and motor neuron disease.…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley